Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Goicoechea

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|March 30, 2007
Human H5N1 influenzaMiguel Goicoechea
Expert Opinion on Pharmacotherapy|February 3, 2007
Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all?Miguel Goicoechea, Brookie Best
Lancet (London, England)|September 9, 2008
Abacavir and increased risk of myocardial infarctionMiguel Goicoechea, Allen McCutchan
The Journal of Infectious Diseases|August 19, 2005
CD4 lymphocyte percentage versus absolute CD4 lymphocyte count in predicting HIV disease progression: an old debate revisitedMiguel Goicoechea, Richard Haubrich
Expert Opinion on Drug Metabolism & Toxicology|July 16, 2008
Efavirenz--still first-line king?Brookie M Best, Miguel Goicoechea
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2004
Treatment of candidal cholangitis with caspofungin therapy in a patient with a liver transplant: documentation of biliary excretion of caspofunginMiguel Goicoechea, Joshua Fierer, Scott Johns
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2006
Concurrent use of efavirenz and oxcarbazepine may not affect efavirenz plasma concentrationsMiguel Goicoechea, Brookie Best, Edmund Capparelli, et al.
Open Forum Infectious Diseases|December 21, 2018
No Impact of Probiotics to Reduce <i>Clostridium difficile</i> Infection in Hospitalized Patients: A Real-world ExperienceMaggie J Box, Kristine N Ortwine, Miguel Goicoechea, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|April 27, 2026
Safety of short versus extended antibiotic therapy for neutropenic fever after hematopoietic cell transplantationLucy Cai, Leah Puglisi, Kyle C Molina, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2010
Prevalence and T-cell phenotype of slow HIV disease progressors with robust HIV replicationMiguel Goicoechea, Davey Smith, Susanne May, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|March 30, 2007
Human H5N1 influenzaMiguel Goicoechea
Expert Opinion on Pharmacotherapy|February 3, 2007
Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all?Miguel Goicoechea, Brookie Best
Lancet (London, England)|September 9, 2008
Abacavir and increased risk of myocardial infarctionMiguel Goicoechea, Allen McCutchan
The Journal of Infectious Diseases|August 19, 2005
CD4 lymphocyte percentage versus absolute CD4 lymphocyte count in predicting HIV disease progression: an old debate revisitedMiguel Goicoechea, Richard Haubrich
Expert Opinion on Drug Metabolism & Toxicology|July 16, 2008
Efavirenz--still first-line king?Brookie M Best, Miguel Goicoechea
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2004
Treatment of candidal cholangitis with caspofungin therapy in a patient with a liver transplant: documentation of biliary excretion of caspofunginMiguel Goicoechea, Joshua Fierer, Scott Johns
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2006
Concurrent use of efavirenz and oxcarbazepine may not affect efavirenz plasma concentrationsMiguel Goicoechea, Brookie Best, Edmund Capparelli, et al.
Open Forum Infectious Diseases|December 21, 2018
No Impact of Probiotics to Reduce <i>Clostridium difficile</i> Infection in Hospitalized Patients: A Real-world ExperienceMaggie J Box, Kristine N Ortwine, Miguel Goicoechea, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|April 27, 2026
Safety of short versus extended antibiotic therapy for neutropenic fever after hematopoietic cell transplantationLucy Cai, Leah Puglisi, Kyle C Molina, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2010
Prevalence and T-cell phenotype of slow HIV disease progressors with robust HIV replicationMiguel Goicoechea, Davey Smith, Susanne May, et al.
Pageof 3